Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Director departure
Merger agrmnt [a]
Appointed director
|
|
VYNE Therapeutics Inc. (MNLO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/16/2019 |
4/A
| BALL KRISTINE M (See Remarks) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 27,766 shares
@ $4.52, valued at
$125.5k
Exercised 80,300 restricted stock units
@ $0 |
|
| 12/16/2019 |
4/A
| Kwon Paul (Chief Scientific Officer) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 27,766 shares
@ $4.52, valued at
$125.5k
Exercised 80,300 restricted stock units
@ $0 |
|
| 12/16/2019 |
4/A
| Basta Steven L (CEO) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Paid exercise price by delivering 85,210 shares
@ $4.52, valued at
$385.1k
Exercised 238,800 restricted stock units
@ $0
Exercised 14,000 options to buy
@ $1.83, valued at
$25.6k
|
|
| 08/08/2019 |
4/A
| Ebel Ted (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 22,500 options
@ $6.02, valued at
$135.5k
|
|
| 08/08/2019 |
4/A
| Royston Aaron (Director) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 22,500 options
@ $6.02, valued at
$135.5k
|
|
| 08/08/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/08/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/08/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/07/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/07/2019 |
4/A
| Kwon Paul (Chief Scientific Officer) has filed a Form 4 on Menlo Therapeutics Inc.|
Txns:
| Granted 80,300 restricted stock units
@ $0 |
|
| 08/07/2019 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 08/10/2018 |
4/A
| FMR LLC (See Remark 1) has filed a Form 4 on Menlo Therapeutics Inc. |
|
|